Cargando…
Design and Synthesis of a Library of Lead-Like 2,4-Bisheterocyclic Substituted Thiophenes as Selective Dyrk/Clk Inhibitors
The Dyrk family of protein kinases is implicated in the pathogenesis of several diseases, including cancer and neurodegeneration. Pharmacological inhibitors were mainly described for Dyrk1A so far, but in fewer cases for Dyrk1B, Dyrk2 or other isoforms. Herein, we report the development and optimiza...
Autores principales: | Schmitt, Christian, Kail, Dagmar, Mariano, Marica, Empting, Martin, Weber, Nadja, Paul, Tamara, Hartmann, Rolf W., Engel, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968014/ https://www.ncbi.nlm.nih.gov/pubmed/24676346 http://dx.doi.org/10.1371/journal.pone.0087851 |
Ejemplares similares
-
SGC-CLK-1: A chemical probe for the Cdc2-like kinases CLK1, CLK2, and CLK4
por: Tiek, Deanna, et al.
Publicado: (2023) -
Marine-Derived 2-Aminoimidazolone Alkaloids. Leucettamine B-Related Polyandrocarpamines Inhibit Mammalian and Protozoan DYRK & CLK Kinases
por: Loaëc, Nadège, et al.
Publicado: (2017) -
Straightforward Access to a New Class of Dual DYRK1A/CLK1 Inhibitors Possessing a Simple Dihydroquinoline Core
por: Ţînţaş, Mihaela-Liliana, et al.
Publicado: (2022) -
Combination CDC-like kinase inhibition (CLK)/Dual-specificity tyrosine-regulated kinase (DYRK) and taxane therapy in CTNNB1-mutated endometrial cancer
por: Corr, Bradley R, et al.
Publicado: (2023) -
Controlling clots with Clk1
por: Williams, Ruth
Publicado: (2006)